Korea

SK Biopharmaceuticals Names Donghoon Lee, Head of Bio Investment Center of SK Inc., as New CEO

Mr. Lee brings expertise in global new biz development to further strengthen SK Biopharmaceuticals as SK Group's key bio business PANGYO, South Korea, Nov. 30, 2022 /PRNewswire/ -- SK Biopharmaceuticals, an innovative global pharmaceutical company, announced that it has named Mr. Donghoon Lee, Ex...

2022-12-01 09:30 2686

The 3rd ACBC IR Pitching: Meet 9 selective content companies from Gwangju, Korea at LA & Silicon Valley

GWANGJU, South Korea, Nov. 30, 2022 /PRNewswire/ -- After incubating for 3 months with various supports, fromOct 31st to Nov 4th, 2022, the Gwangju Information & Culture Industry Promotion Agency (GICON) has brought 9 Korean companies toLos Angeles and Silicon Valley under the 3rd ACBC IR Pitchin...

2022-11-30 19:20 1901

COSMAX Group Expands Business to Pet Care...Targeting $200B Market

* Started operations of pet supplements manufacturing plant * Produces 'human-grade' products with differentiated ingredients * Plans to expand pet care business from supplements to cosmetics SEONGNAM, South Korea, Nov. 29, 2022 /PRNewswire/ -- COSMAX Group, the leader in the global cosmetic...

2022-11-29 22:00 4449

Yuyu Pharma Plans to Enter the U.S. and European Markets for Hair Loss Treatment

SEOUL, South Korea, Nov. 29, 2022 /PRNewswire/ -- At the World Congress for Hair Research 2022 (Melbourne, Australia), Yuyu Pharma shared its plans to conduct clinical trials in the U.S. andEurope for its Dutasteride Tablet ("DUT") for the treatment of Androgenetic Alopecia ("AGA").

2022-11-29 16:20 5022

Hyundai Mobis Introduces LogisticsㆍCollaborative Robotics Solutions Featuring its Key Future Mobility Technologies

* Development of mobile collaborative robots and self-driving logistics robots … an integrated system for controlling multiple robots. * Implementation in general manufacturing sites and smart factories … expected to expand human-friendly robotics services. * Robo-wheel technology anticipate...

2022-11-28 21:00 5021

VUNO Showcases their AI Solutions and Research Results at RSNA 2022

SEOUL, South Korea, Nov. 25, 2022 /PRNewswire/ -- VUNO Inc., a leading South Korean artificial intelligence (AI) developer, announced that it will participate in the Radiological Society ofNorth America 2022 (RSNA 2022). This year, VUNO will focus on highlighting how their breakthrough AI technol...

2022-11-25 23:00 14056

New study on deep learning technology for improving MRI image quality published in European Radiology

SwiftMR™, an AI-powered MRI reconstruction solution from AIRS Medical proved its performance for enhancing the image quality of 3D high-resolution MRI SEOUL, South Korea, Nov. 25, 2022 /PRNewswire/ -- A recent study published in European Radiology

2022-11-25 23:00 13698

Daesung Smart Hive Plasma Ozone Storage New Product Launch

* Smart Plasma Ozone Storage Procurement Agency's innovative products to expand the distribution to the private sector SEOUL, South Korea, Nov. 25, 2022 /PRNewswire/ -- DAESUNG Co., Ltd., which produces portable automatic beekeeping machines, has released a number of products that convert tradi...

2022-11-25 22:00 13467

Neurophet, to participate in the Radiological Society of North America RSNA 2022

̵ Introducing 4 products at the booth including the main product Neurophet AQUA ̵ Conducting in-depth discussions jointly team members from R&D and cooperation with several global companies SEOUL, South Korea, Nov. 25, 2022 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution comp...

2022-11-25 22:00 12875

Seoul Metropolitan Government hosts the "International Forum on Safety Income" in December to solve poverty and inequality

SEOUL, South Korea, Nov. 25, 2022 /PRNewswire/ -- Seoul International Forum on Safety Income 2022 (hereinafter referred to as "Forum") will be held inSeoul on December 6 (Tue) where guaranteed income experiment researchers of various countries gather to solve the global challenges of poverty and ...

2022-11-25 22:00 12715

Chemotherapy may be completed within 8 days with two doses of Polytaxel, an innovative anticancer drug from South Korea's biotech firm

* Polytaxel, a novel pain-free anticancer drug, may not require break periods * A new standard of care, more convenient than docetaxel, is suggested * Hyundai Bioscience to enter clinical trial on pancreatic cancer in Australia * Patient-centered chemotherapy to enable outpatients to live nor...

2022-11-25 21:00 13064

Hugel's 'Letybo' First in Korea to Obtain Marketing Approval from Australia

- Obtained marketing approval on the 23rd (local time) from the Therapeutic Goods Administration (TGA) ofAustralia for the indication of glabellar lines - First shipment and local launch planned for Q1 2023...Plans to cooperate with major chain clinics and key opinion leaders SEOUL, South Korea,...

2022-11-24 22:00 6303

Edenlux launches AI-based service "Otus Plus Eye Health Care Report"

SEOUL, South Korea, Nov. 24, 2022 /PRNewswire/ -- On November 24, Edenlux (CEO Sy Park) announced that it will provide an artificial intelligence (AI) eye health management report for the users of Otus Plus, its flagship product.

2022-11-24 22:00 4843

Korea Ginseng Corp.: As an adaptogenic herb, Korean red ginseng boosts the human immune response

*  KORESELECT Immune receives the 2022 Taste For Life Immunity Essential award CERRITOS, Calif., Nov. 23, 2022 /PRNewswire/ -- Korean Ginseng Corp., the world's number one Korean red ginseng brand, is highlighting Korean red ginseng as another way to stay healthy.

2022-11-23 23:00 4496

J INTS BIO, M.D Anderson Cancer Center joint development - oral HSP90 inhibitor 'JIN-001', presentation of preclinical assessment at 2022 SNO Annual Meeting

SEOUL, South Korea, Nov. 23, 2022 /PRNewswire/ -- J INTS BIO announced that the preclinical assessment of JIN-001 or MPT0B640, a novel, orally administered 2nd generation HSP90 (heat shock protein 90) inhibitor, was presented during the 2022 edition of the Society for Neuro-Oncology Conference, h...

2022-11-23 15:18 2408

Lunit Becomes the First Medical Software Company in Asia-Pacific to Become MDR CE and UKCA Certified

* Lunit becomes first software as a medical device (SaMD) company in APAC to become MDR CE and UKCA certified * MDR and UKCA certifications are required for all Europe and UK commercial medical devices with implementation deadlines set to 2024 SEOUL, South Korea, Nov. 21, 2022 /PRNewswire/ --...

2022-11-21 21:00 3558

Where your days begin again: Medical Korea

NEW YORK and SEOUL, South Korea, Nov. 21, 2022 /PRNewswire/ -- The number of international medical tourists visiting Korea increased by 25% from 110,000 in 2020 to 140,000 in 2021 despite the impact of the COVID-19 pandemic. Medi...

2022-11-21 15:49 2411

MEDICOX Signs Contract with ORAMED to Distribute Oral Insulin in South Korea

- MEDICOX secures distribution right for ORAMED's oral insulin in South Korea after phase 3 of FDA approval - Contract scale up to 18 million dollars for developmental milestone and up to 15% royalty for sales - ORAMED says 1 in 7 Korean adults over 30 have diabetes and expects market potential ...

2022-11-18 17:11 3226

The innovative Startup 'Dot' won Best of Innovation at CES 2023 with 'Dot Pad'

* Startup Dot Inc. won Best of Innovation in Accessibility category at CES 2023.  * Dot Inc. is the Honoree in three categories after being nominated as the finalist in each of the threecategories. * Until November 2022, 25 billion won to the total amount in cumulative investment and 130 pa...

2022-11-18 15:53 2826

TRAVUT opens a travel information service, Handy Info Center that provides highly reliable travel information through real-time chat with locals

SEOUL, South Korea, Nov. 18, 2022 /PRNewswire/ -- Travel platform, TRAVUT published by REDBIK Co., Ltd opens a real-time travel information service,Handy Info Center, to provide travelers with the right travel information at right time.  Mob...

2022-11-18 15:47 2724
1 ... 105106107108109110111 ... 141